[
    {
        "paperId": "49edf9696c93490a3f377a883240b7f5f487ae5c",
        "title": "Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?",
        "abstract": "AnnemiekAMEStenger, Pieternella MHoutman,GeorgeAWBruynThepotentialvalueoftheantifolatemethotrexate(N1O-methylaminopterin) in the treatment ofrheumatoid arthritis (RA) was first recognisedin 1951.' Thelow dose drug administration individeddoses 12 hoursapartwasdevelopedforthe treatment ofpatients with psoriasis, basedonpropertiesofpsoriaticepithelial cells andthebiologicalactionofmethotrexateonthesecells.2To date its mode of action has not been wellestablished.3 It is generally believed that lowdose weekly pulses of methotrexate are notmarkedlyimmunosuppressive. Thisis basedonthe",
        "year": 1992,
        "citation_count": 17,
        "relevance": 2,
        "explanation": "The hypothesis in this paper is at least partially dependent on the findings of the source paper. The source paper investigates the effect of folinic acid supplementation on low-dose methotrexate treatment in patients with rheumatoid arthritis, and this paper explores the potential value of folate supplementation in a similar context, suggesting that the authors are building on the source paper's results."
    }
]